Comparative cost analysis of Eluvia™ versus Zilver® PTX® in treating femoropopliteal peripheral artery disease utilizing real-world data.
Aim: To compare the hospital-based costs among patients with femoropopliteal artery (FPA) disease treated with Eluvia™ versus Zilver® PTX® drug-eluting stents using a large real-world USA hospital database. Materials & methods: This retrospective study included adults in the Premier Healthcare Database who underwent lo...